               SEQUENCE LISTING

<110> OREGA BIOTECH

<120> ANTAGONISTS OF IL-17 ISOFORMS AND THEIR USES

<130> O57-B-37928 PCT II

<150> PCT/EP2012/061134
<151> 2012-06-12

<160> 14

<170> BiSSAP 1.2

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="IL17B # NM_014443.2"
      /organism="Artificial Sequence"

<400> 1
gccactggac ctggtgtcac g                                              21


<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..22
<223> /mol_type="unassigned DNA"
      /note="IL17B # NM_014443.2"
      /organism="Artificial Sequence"

<400> 2
ctggggtcgt ggttgatgct gt                                             22


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="IL17C # NM_013278.3"
      /organism="Artificial Sequence"

<400> 3
tgccaagtgg gggcaggctt                                                20


<210> 4
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..24
<223> /mol_type="unassigned DNA"
      /note="IL17C # NM_013278.3"
      /organism="Artificial Sequence"

<400> 4
cgtgtccaca cggtatctcc aggg                                           24


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..23
<223> /mol_type="unassigned DNA"
      /note="IL17D # NM_138284.1"
      /organism="Artificial Sequence"

<400> 5
gccctgggcc tacagaatct cct                                            23


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="IL17D # NM_138284.1"
      /organism="Artificial Sequence"

<400> 6
cctcggtgta gacggaacgg c                                              21


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="IL17RB # NM_018725.3"
      /organism="Artificial Sequence"

<400> 7
taccccgaga gccgaccgtt                                                20


<210> 8
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="IL17RB # NM_018725.3"
      /organism="Artificial Sequence"

<400> 8
ggcatctgcc cggagtaccc a                                              21


<210> 9
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="IL17RE # NM_153480.1"
      /organism="Artificial Sequence"

<400> 9
ccaccttcag gccatgcagc c                                              21


<210> 10
<211> 22
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..22
<223> /mol_type="unassigned DNA"
      /note="IL17RE # NM_153480.1"
      /organism="Artificial Sequence"

<400> 10
ctgtcatccg tgtgggaggc ca                                             22


<210> 11
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="GAPDH"
      /organism="Artificial Sequence"

<400> 11
gaaggtgaag gtcggagtca                                                20


<210> 12
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="GAPDH"
      /organism="Artificial Sequence"

<400> 12
gacaagcttc ccgttctcag                                                20


<210> 13
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..24
<223> /mol_type="unassigned DNA"
      /note="ACTIN"
      /organism="Artificial Sequence"

<400> 13
cagccatgta cgttgctatc cagg                                           24


<210> 14
<211> 23
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..23
<223> /mol_type="unassigned DNA"
      /note="ACTIN"
      /organism="Artificial Sequence"

<400> 14
aggtccagac gcaggatggc atg                                            23


